Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24
Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24
高盛以买入评级启动对Olema Pharmicals的报道,宣布目标股价为24美元
Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $24.
高盛分析师理查德·劳以买入评级启动了对奥莱玛制药(纳斯达克股票代码:OLMA)的报道,并宣布目标股价为24美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。